Mature B-Cell Non-Hodgkin Lymphoma — Trials

Mature B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

2,506 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 792
Recruiting: 402
Ph III recruiting: 40
Growth YoY: +9.6%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (393)

clinicaltrialsPublishedShowing 151–200 of 514 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04792489	DALY II USA/ MB-CART2019.1 for DLBCL	recruiting	Phase 2	315	Miltenyi Biomedicine GmbHINDUSTRY	2	Jul 13, 2026	clinicaltrials
NCT07599423	A Study of Glofitamab Plus GemOx Compared With Standard of Care in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma	not yet recruiting	Phase 2	96	The First Affiliated Hospital of Soochow UniversityOTHER	1	Jul 13, 2026	clinicaltrials